Wegovy® (semaglutide) is one of the most clinically proven and effective weight loss treatments currently available, with impressive results demonstrated in large-scale international trials.
🔬 Clinical Evidence:
- In the STEP 1 trial, patients taking Wegovy lost an average of 15% of their body weight over 68 weeks, when combined with healthy lifestyle changes.
- Two-thirds of participants lost more than 10% of their body weight.
- Nearly one-third of users lost over 20% of their body weight.
- Average total weight loss: Over 15kg.
These results were achieved with once-weekly injections of semaglutide 2.4 mg, in combination with a calorie-controlled diet and increased physical activity.
🧪 Comparison with Other Treatments:
While Wegovy is highly effective, Mounjaro® (tirzepatide) – a dual GIP/GLP-1 receptor agonist – has shown even greater weight loss outcomes in the SURMOUNT trials with an average weight loss of up to 22.5% of body weight over 72 weeks. Both medications are supported by strong clinical evidence, and your choice of treatment should be tailored to your individual needs with the help of a qualified clinician.